Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
BTSG Stock Forecast 2026-2027
$63.23
Current Price
$12.41B
Market Cap
Buy 17
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to BTSG Price Targets
+12.3%
To High Target of $71.00
+0.4%
To Median Target of $63.50
-22.5%
To Low Target of $49.00
BTSG Price Momentum
+10.2%
1 Week Change
+8.3%
1 Month Change
+198.5%
1 Year Change
+68.8%
Year-to-Date Change
-1.5%
From 52W High of $64.18
+232.6%
From 52W Low of $19.01
📊 TOP ANALYST CALLS
Did BTSG Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if BrightSpring is one of their latest high-conviction picks.
Latest BTSG Stock Price Targets & Analyst Predictions
Based on our analysis of 3 Wall Street analysts, BTSG has a bullish consensus with a median price target of $63.50 (ranging from $49.00 to $71.00). The overall analyst rating is Strong Buy (9.8/10). Currently trading at $63.23, the median forecast implies a 0.4% upside. This outlook is supported by 17 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Scott Fidel at Goldman Sachs, projecting a 12.3% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
BTSG Analyst Ratings
17
Buy
0
Hold
0
Sell
BTSG Price Target Range
Low
$49.00
Average
$63.50
High
$71.00
Current: $63.23
Latest BTSG Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for BTSG.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 8, 2026 | Goldman Sachs | Scott Fidel | Buy | Initiates | $71.00 |
| Jun 2, 2026 | Morgan Stanley | Erin Wright | Overweight | Maintains | $71.00 |
| May 6, 2026 | Morgan Stanley | Overweight | Maintains | $N/A | |
| May 5, 2026 | Mizuho | Outperform | Maintains | $N/A | |
| May 4, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| May 4, 2026 | TD Cowen | Buy | Maintains | $N/A | |
| May 4, 2026 | Keybanc | Overweight | Maintains | $N/A | |
| May 4, 2026 | Stephens & Co. | Overweight | Maintains | $N/A | |
| May 4, 2026 | BMO Capital | Outperform | Maintains | $N/A | |
| May 4, 2026 | BTIG | Buy | Maintains | $N/A | |
| Mar 19, 2026 | BTIG | Buy | Reiterates | $N/A | |
| Mar 18, 2026 | UBS | Buy | Maintains | $N/A | |
| Mar 18, 2026 | Mizuho | Outperform | Maintains | $N/A | |
| Mar 4, 2026 | Morgan Stanley | Overweight | Maintains | $N/A | |
| Mar 3, 2026 | Mizuho | Outperform | Maintains | $N/A | |
| Mar 2, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| Mar 2, 2026 | BTIG | Buy | Reiterates | $N/A | |
| Feb 2, 2026 | BTIG | Buy | Maintains | $N/A | |
| Jan 7, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| Dec 23, 2025 | BTIG | Buy | Maintains | $N/A |
BrightSpring Health Services, Inc. (BTSG) Competitors
The following stocks are similar to BrightSpring based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
BTSG
Brightspring
mkt cap
12.41B
BrightSpring Health Services, Inc. (BTSG) Financial Data
BrightSpring Health Services, Inc. has a market capitalization of $12.41B with a P/E ratio of 82.1x. The company generates $13.65B in trailing twelve-month revenue with a 2.3% profit margin.
Revenue growth is +25.6% quarter-over-quarter, while maintaining an operating margin of +3.4% and return on equity of +9.2%.
Valuation Metrics
Market Cap
$12.41B
Enterprise Value
$14.79B
P/E Ratio
82.1x
PEG Ratio
0.2x
Price/Sales
0.9x
Growth & Margins
Revenue Growth (YoY)
+25.6%
Gross Margin
+13.3%
Operating Margin
+3.4%
Net Margin
+2.3%
EPS Growth
+403.6%
Financial Health
Cash/Price Ratio
+6.8%
Current Ratio
1.7x
Debt/Equity
135.7x
ROE
+9.2%
ROA
+4.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
BrightSpring Health Services, Inc. (BTSG) Business Model
About BrightSpring Health Services, Inc.
What They Do
Provides home and community-based health services.
Business Model
BrightSpring Health Services operates by delivering integrated health services tailored for complex populations. They generate revenue by offering a range of services, including home health care, hospice, and pharmacy management, primarily funded through Medicare, Medicaid, and private insurance programs.
Additional Information
Founded in 1974 and based in Louisville, Kentucky, the company focuses on leveraging technology to improve patient outcomes. Their use of electronic health records, telehealth, and data analytics underscores their commitment to innovative, patient-centered care for high-need individuals.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
23,500
CEO
Mr. Jon B. Rousseau
Country
United States
IPO Year
2024
Website
www.brightspringhealth.comBrightSpring Health Services, Inc. (BTSG) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Screening for Top Value Stocks with Growth
Value does exist in this market. Find it using the PEG and P/S ratios.
Jun 12, 2026
By Tracey Ryniec
Value Investor
4 Top-Rated Stocks to Pick With Impressive Cash Flow Growth
BrightSpring, StoneX, Cimpress and Flexsteel stand out as buy-worthy stocks with rising cash flows and upward earnings estimate revisions.
Jun 12, 2026
By Moumita C. Chattopadhyay
Analyst Blog
Danaher Boosts Product Portfolio With the Acquisition of Masimo
DHR closes its $9.9B Masimo acquisition, adding AI-enabled patient-monitoring and sensor technologies to expand diagnostics solutions.
Jun 12, 2026
By Zacks Equity Research
Analyst Blog
Latest News
Quick Summary
BrightSpring Health Services (NASDAQ: BTSG) reports growth driven by strong performance in its pharmacy and provider sectors, with specialty pharmacy as a significant contributor.
Why It Matters
BrightSpring's growth indicates strong operational performance, particularly in specialty pharmacy, which could enhance revenue stability and attract investor interest in BTSG.
Source: MarketBeat
Market Sentiment:
Positive
Quick Summary
BrightSpring Health Services, Inc. (BTSG) presented at the Goldman Sachs 47th Annual Global Healthcare Conference, showcasing their strategic initiatives and performance insights for 2026.
Why It Matters
BrightSpring Health Services' presentation at a major healthcare conference signals potential growth opportunities and investor interest, impacting stock performance and market perception.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
BrightSpring Health Services (NASDAQ: BTSG) appointed Dr. Nigam H. Shah as a Class III Board member on June 11, 2026. He will also join the Quality and Compliance Committee.
Why It Matters
The appointment of Dr. Nigam H. Shah to BrightSpring's Board enhances governance and expertise, potentially improving operational effectiveness and investor confidence in the company's strategic direction.
Source: GlobeNewsWire
Market Sentiment:
Neutral
BrightSpring Health Services, Inc. (BTSG) is on the Move, Here's Why the Trend Could be Sustainable
1 day ago
Quick Summary
BrightSpring Health Services, Inc. (BTSG) shows potential for investors, identified as a strong stock with recent price momentum according to a "Recent Price Strength" screening.
Why It Matters
BrightSpring Health Services shows strong fundamentals and recent price momentum, indicating potential for growth, which could attract investors seeking profitable opportunities.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
BrightSpring, StoneX, Cimpress, and Flexsteel are highlighted as strong buy candidates due to increasing cash flows and positive revisions in earnings estimates.
Why It Matters
Rising cash flows and upward earnings estimates signal strong financial health and growth potential in BrightSpring, StoneX, Cimpress, and Flexsteel, making them attractive investment opportunities.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
BTSG, BDSX, and HQY are positioned to gain from growth in digital health, healthcare analytics, and nursing care, which may mitigate workforce challenges.
Why It Matters
BTSG, BDSX, and HQY are positioned for growth as demand for digital health and analytics rises, potentially leading to increased revenues amid workforce challenges in healthcare.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About BTSG Stock
What is BrightSpring Health Services, Inc.'s (BTSG) stock forecast for 2026?
Based on our analysis of 3 Wall Street analysts, BrightSpring Health Services, Inc. (BTSG) has a median price target of $63.50. The highest price target is $71.00 and the lowest is $49.00.
Is BTSG stock a good investment in 2026?
According to current analyst ratings, BTSG has 17 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $63.23. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for BTSG stock?
Wall Street analysts predict BTSG stock could reach $63.50 in the next 12 months. This represents a 0.4% increase from the current price of $63.23. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is BrightSpring Health Services, Inc.'s business model?
BrightSpring Health Services operates by delivering integrated health services tailored for complex populations. They generate revenue by offering a range of services, including home health care, hospice, and pharmacy management, primarily funded through Medicare, Medicaid, and private insurance programs.
What is the highest forecasted price for BTSG BrightSpring Health Services, Inc.?
The highest price target for BTSG is $71.00 from Scott Fidel at Goldman Sachs, which represents a 12.3% increase from the current price of $63.23.
What is the lowest forecasted price for BTSG BrightSpring Health Services, Inc.?
The lowest price target for BTSG is $49.00 from at , which represents a -22.5% decrease from the current price of $63.23.
What is the overall BTSG consensus from analysts for BrightSpring Health Services, Inc.?
The overall analyst consensus for BTSG is bullish. Out of 3 Wall Street analysts, 17 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $63.50.
How accurate are BTSG stock price projections?
Stock price projections, including those for BrightSpring Health Services, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 14, 2026 5:33 AM UTC